(R)-N*1*-[2,2-Dimethyl-1-((R)-methylcarbamoyl)-propyl]-N*4*-hydroxy-2-isobutyl-succinamide

ID: ALA306412

PubChem CID: 44313734

Max Phase: Preclinical

Molecular Formula: C15H29N3O4

Molecular Weight: 315.41

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Synonyms: Ro-37-9790 | Ro-37-9790|CHEMBL306412|BDBM50290086|(R)-N*1*-[2,2-Dimethyl-1-((R)-methylcarbamoyl)-propyl]-N*4*-hydroxy-2-isobutyl-succinamide

Canonical SMILES:  CNC(=O)[C@H](NC(=O)[C@@H](CC(=O)NO)CC(C)C)C(C)(C)C

Standard InChI:  InChI=1S/C15H29N3O4/c1-9(2)7-10(8-11(19)18-22)13(20)17-12(14(21)16-6)15(3,4)5/h9-10,12,22H,7-8H2,1-6H3,(H,16,21)(H,17,20)(H,18,19)/t10-,12+/m1/s1

Standard InChI Key:  QRXOZHSEEGNRFC-PWSUYJOCSA-N

Molfile:  

     RDKit          2D

 22 21  0  0  1  0  0  0  0  0999 V2000
    3.6542   -1.0042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9417   -1.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3667   -1.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0875   -1.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2292   -1.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8000   -1.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3667   -2.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5167   -1.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9417   -2.2417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8000   -1.4167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2292   -0.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8000   -0.1792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0875   -0.1792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0875   -1.4167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0875   -2.2417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9417    0.2333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6167   -2.6042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2250   -2.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2792   -3.0125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8000    0.2333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7250    1.0333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6542    0.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  3  1  0
  5  2  1  0
  6  8  1  0
  3  7  1  1
  8  5  1  0
  9  2  2  0
 10  4  2  0
  5 11  1  1
 12  6  2  0
 13  4  1  0
 14  6  1  0
 15 14  1  0
 16 11  1  0
 17  7  1  0
 18  7  1  0
 19  7  1  0
 20 13  1  0
 21 16  1  0
 22 16  1  0
M  END

Associated Targets(Human)

MMP2 Tchem Collagenase (153 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP3 Tchem Matrix metalloproteinase 3 (3433 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP9 Tchem Matrix metalloproteinase 9 (6779 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 315.41Molecular Weight (Monoisotopic): 315.2158AlogP: 0.82#Rotatable Bonds: 7
Polar Surface Area: 107.53Molecular Species: NEUTRALHBA: 4HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 8.90CX Basic pKa: CX LogP: 0.66CX LogD: 0.64
Aromatic Rings: Heavy Atoms: 22QED Weighted: 0.41Np Likeness Score: 0.53

References

1. Broadhurst M, Brown P, Lawton G, Ballantyne N, Borkakoti N, Bottomley K, Cooper M, Eatherton A, Kilford I, Malsher P, Nixon J, Lewis E, Sutton B, Johnson W.  (1997)  Design and synthesis of the cartilage protective agent (CPA, Ro32-3555),  (17): [10.1016/S0960-894X(97)00416-2]

Source